Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Professionalism in court
Cheshire, William P. , Hutchins, John C., Cheshire, William P

Neurology Clinical Practice | August 18, 2014 | Volume: 4 | Issue: 4 | Pages: 335-341

10.1212/cpj.0000000000000041 | PMID 25279255 Get It

Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
Abudiab, Muaz M. , Freiman, Samuel Unzek

World Journal of Nuclear Medicine | August 18, 2014 | Volume: 13 | Issue: 02 | Pages: 142-143

10.4103/1450-1147.139148 | PMID 25191132 Get It

Regadenoson is a widely used and well-tolerated vasodilator agent for pharmacologic stress myocardial perfusing imaging. In patients at higher risk of adverse reactions such as those with end stage renal disease, it can be reversed with early administration of aminophylline. However, little is known about late administration of aminophylline. This case report describes the efficacy of late aminophylline use in patients with end stage renal disease. Possible explanations for the prolonged pharmacodynamic effect of regadenoson in this group are discussed.
Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses
Keith, Phillip J., Wetter, David A. , Lehman, Julia S. , Wilson, John , Lehman, Julia S

British Journal of Dermatology | August 18, 2014 | Volume: 171 | Issue: 6 | Pages: 1307-1317

10.1111/bjd.13355 | PMID 25130049 Get It

Esophageal leukoplakia: a rare cause of white patches in esophagus with malignant potential
Ratuapli, Shiva K., Thind, Komal, Fleischer, David E., Shiff, Arthur D., Foxx–Orenstein, Amy E., Lam‐Himlin, Dora

Diseases of the Esophagus | August 18, 2014 | Volume: 29 | Issue: 7 | Pages: 885-885

10.1111/dote.12275 | PMID 25130786 Get It

Saline-Coupled Bipolar Sealing in Simultaneous Bilateral Total Knee Arthroplasty
Austin, Daniel C. , Derman, Peter B. , Clement, R. Carter , Garino, Jonathan P. , Kamath, Atul F, Kamath, Atul F. , Lee, Gwo‐Chin

Clinics in Orthopedic Surgery | August 18, 2014 | Volume: 6 | Issue: 3 | Pages: 298

10.4055/cios.2014.6.3.298 | PMID 25177455 Get It

Circulatory Support with Venoarterial ECMO Unsuccessful in Aiding Endogenous Diltiazem Clearance after Overdose
Frazee, Erin N., Lee, Sarah J., Kalimullah, Ejaaz A., Personett, Heather A. , Nelson, Darlene R. , Frazee, Erin N.

Case Reports in Critical Care | August 17, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-5

10.1155/2014/969578 | PMID 25202457 Get It

Introduction.In cardiovascular collapse from diltiazem poisoning, extracorporeal membrane oxygenation (ECMO) may offer circulatory support sufficient to preserve endogenous hepatic drug clearance. Little is known about patient outcomes and diltiazem toxicokinetics in this setting.Case Report.A 36-year-old woman with a history of myocardial bridging syndrome presented with chest pain for which she self-medicated with 2.4 g of sustained release diltiazem over the course of 8 hours. Hemodynamics and mentation were satisfactory on presentation, but precipitously deteriorated after ICU transfer. She was given fluids, calcium, vasopressors, glucagon, high-dose insulin, and lipid emulsion. Due to circulatory collapse and multiorgan failure including ischemic hepatopathy, she underwent transvenous pacing and emergent initiation of venoarterial ECMO. The peak diltiazem level was 13150 ng/mL (normal 100–200 ng/mL) and it remained elevated at 6340 ng/mL at hour 90. Unfortunately, the patient developed multiple complications which resulted in her death on ICU day 9.Conclusion.This case describes the unsuccessful use of ECMO for diltiazem intoxication. Although past reports suggest that support with ECMO may facilitate endogenous diltiazem clearance, it may be dependent on preserved hepatic function at the time of cannulation, a factor not present in this case.
Hyperuricemia and Incident Cardiovascular Disease and Noncardiac Vascular Events in Patients with Rheumatoid Arthritis
Kuo, Daniel , Crowson, Cynthia S. , Gabriel, Sherine E., Matteson, Eric L.

International Journal of Rheumatology | August 17, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-7

10.1155/2014/523897 | PMID 25197282 Get It

Objective. To evaluate whether hyperuricemia is a risk factor for cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA).Methods. A population-based inception cohort of patients diagnosed between 1980 and 2007 with adult-onset RA was assembled. A comparison cohort of age- and sex-matched subjects without RA (non-RA) was also assembled. All clinically obtained uric acid values were collected. CVD and noncardiac vascular events were recorded for each patient. Cox proportional hazards models were used to assess the impact of hyperuricemia on development of CVD, mortality, and noncardiac vascular disease.Results. In patients without RA, hyperuricemia was associated with heart failure (HR: 1.95; 95% CI: 1.13–3.39) and CVD (HR: 1.59; 95% CI: 0.99–2.55). In patients with RA, hyperuricemia was not significantly associated with CVD but was significantly associated with peripheral arterial events (HR: 2.52; 95% CI: 1.17–5.42). Hyperuricemia appeared to be more strongly associated with mortality among RA patients (HR: 1.96; 95% CI: 1.45–2.65) than among the non-RA subjects (HR: 1.57; 95% CI: 1.09–2.24).Conclusion. In patients with RA, hyperuricemia was a significant predictor of peripheral arterial events and mortality but not of CVD.
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)
Sylvia, Louisa G. , Shelton, Richard C. , Kemp, David E. , Bernstein, Emily E. , Friedman, Edward S., Brody, Benjamin D. , Tohen, Mauricio , Bowden, Charles L., Ketter, Terence A. , Deckersbach, Thilo , Thase, Michael E., Reilly-Harrington, Noreen A. , Nierenberg, Andrew A. , Rabideau, Dustin J. , Kinrys, Gustavo , Kocsis, James H., Kamali, Masoud , McInnis, Melvin G. , Calabrese, Joseph R. , McElroy, Susan L. , Singh, Vivek Kumar , Bobo, William V. , Kamali, Masoud , McInnis, Melvin G

Bipolar Disorders | August 16, 2014 | Volume: 17 | Issue: 2 | Pages: 212-223

10.1111/bdi.12243 | PMID 25130321 Get It

ObjectivesIndividuals with bipolar disorder have high rates of other medical comorbidity, which is associated with higher mortality rates and worse course of illness. The present study examined common predictors of medical comorbidity.MethodsThe Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE) enrolled 482 participants with bipolar I or bipolar II disorder in a six‐month, randomized comparative effectiveness trial. Baseline assessments included current and lifetime DSM‐IV‐TR diagnoses, demographic information, psychiatric and medical history, severity of psychiatric symptoms, level of functioning, and a fasting blood draw. Medical comorbidities were categorized into two groups: cardiometabolic (e.g., diabetes, hyperlipidemia, and metabolic syndrome) and non‐cardiovascular (e.g., seizures, asthma, and cancer). Additionally, we looked at comorbid substance use (e.g., smoking and drug dependence).ResultsWe found that 96.3% of participants had at least one other medical comorbidity. Older age predicted a greater likelihood of having a cardiometabolic condition. Early age of onset of bipolar symptoms was associated with a lower chance of having a cardiometabolic condition, but a greater chance of having other types of medical comorbidity. Additional predictors of other medical comorbidities in bipolar disorder included more time spent depressed, less time spent manic/hypomanic, and longer duration of illness. Medications associated with weight gain were associated with low high‐density lipoprotein and abnormal triglycerides.ConclusionsThere appears to be a substantial medical burden associated with bipolar disorder, highlighting the need for collaborative care among psychiatric and general medical providers to address both psychiatric and other medical needs concomitantly in this group of patients.
Faculty Opinions recommendation of Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.
Coddington, Charles C. , Shenoy, Chandra C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 15, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718485868.793498561 Get It

Response to letter by Dr. Marc Hershenson (exposure of airway smooth muscle cells to cigarette smoke extract)
Aravamudan, Bharathi, Delmotte, Philippe , Vassallo, Robert , Sieck, Gary C. , Prakash, Y. S. , Thompson, Michael D. , Pabelick, Christina M. , Prakash, Y S , Sieck, Gary , Vassallo, Robert

American Journal of Physiology-Lung Cellular and Molecular Physiology | August 15, 2014 | Volume: 307 | Issue: 4 | Pages: L346-L346

10.1152/ajplung.00194.2014 | PMID 25128539 Get It